158 related articles for article (PubMed ID: 36463240)
21. Novel blood-based hypomethylation of SH3BP5 is associated with very early-stage lung adenocarcinoma.
Qiao R; Zhong R; Liu C; Di F; Zhang Z; Wang L; Xu T; Wang Y; Dai L; Gu W; Han B; Yang R
Genes Genomics; 2022 Apr; 44(4):445-453. PubMed ID: 34783986
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide CpG island methylation analyses in non-small cell lung cancer patients.
Heller G; Babinsky VN; Ziegler B; Weinzierl M; Noll C; Altenberger C; Müllauer L; Dekan G; Grin Y; Lang G; End-Pfützenreuter A; Steiner I; Zehetmayer S; Döme B; Arns BM; Fong KM; Wright CM; Yang IA; Klepetko W; Posch M; Zielinski CC; Zöchbauer-Müller S
Carcinogenesis; 2013 Mar; 34(3):513-21. PubMed ID: 23172663
[TBL] [Abstract][Full Text] [Related]
23. [Peripheral blood
Zang Z; Qiao R; Zhu Q; Zhou X; Gu W; Han B; Yang R
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):349-359. PubMed ID: 37087578
[TBL] [Abstract][Full Text] [Related]
24. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
Xu XL; Gong Y; Zhao DP
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913
[TBL] [Abstract][Full Text] [Related]
25. Identification of diagnostic DNA methylation biomarkers specific for early-stage lung adenocarcinoma.
Cai Q; Zhang P; He B; Zhao Z; Zhang Y; Peng X; Xie H; Wang X
Cancer Genet; 2020 Aug; 246-247():1-11. PubMed ID: 32805686
[TBL] [Abstract][Full Text] [Related]
26. A prognosis-related molecular subtype for early-stage non-small lung cell carcinoma by multi-omics integration analysis.
Yang K; Wu Y
BMC Cancer; 2021 Feb; 21(1):128. PubMed ID: 33549049
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic-smoking interaction reveals histologically heterogeneous effects of TRIM27 DNA methylation on overall survival among early-stage NSCLC patients.
Ji X; Lin L; Shen S; Dong X; Chen C; Li Y; Zhu Y; Huang H; Chen J; Chen X; Wei L; He J; Duan W; Su L; Jiang Y; Fan J; Guan J; You D; Shafer A; Bjaanaes MM; Karlsson A; Planck M; Staaf J; Helland Å; Esteller M; Wei Y; Zhang R; Chen F; Christiani DC
Mol Oncol; 2020 Nov; 14(11):2759-2774. PubMed ID: 33448640
[TBL] [Abstract][Full Text] [Related]
28. High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer.
Rauch TA; Zhong X; Wu X; Wang M; Kernstine KH; Wang Z; Riggs AD; Pfeifer GP
Proc Natl Acad Sci U S A; 2008 Jan; 105(1):252-7. PubMed ID: 18162535
[TBL] [Abstract][Full Text] [Related]
29. CpG islands in MyD88 and ASC/PYCARD/TMS1 promoter regions are differentially methylated in head and neck squamous cell carcinoma and primary lung squamous cell carcinoma.
Šutić M; Baranašić J; Bilić LK; Bilić M; Jakovčević A; Brčić L; Seiwerth S; Jakopović M; Samaržija M; Zechner U; Knežević J
Diagn Pathol; 2021 Feb; 16(1):17. PubMed ID: 33637109
[TBL] [Abstract][Full Text] [Related]
30.
Zhang W; Li T; Hu B; Li H
Technol Cancer Res Treat; 2020; 19():1533033820957030. PubMed ID: 33084541
[TBL] [Abstract][Full Text] [Related]
31. The signature of HBV-related liver disease in peripheral blood mononuclear cell DNA methylation.
Li K; Qin L; Jiang S; Li A; Zhang C; Liu G; Sun J; Sun H; Zhao Y; Li N; Zhang Y
Clin Epigenetics; 2020 Jun; 12(1):81. PubMed ID: 32513305
[TBL] [Abstract][Full Text] [Related]
32. Role of downregulated ADARB1 in lung squamous cell carcinoma.
Wang X; Ren X; Liu W; Chen X; Wei J; Gong Z; Yan Y; Xu Z
Mol Med Rep; 2020 Mar; 21(3):1517-1526. PubMed ID: 32016472
[TBL] [Abstract][Full Text] [Related]
33. Imprinting of Skin/Inflammation Homing in CD4+ T Cells Is Controlled by DNA Methylation within the Fucosyltransferase 7 Gene.
Pink M; Ratsch BA; Mardahl M; Durek P; Polansky JK; Karl M; Baumgrass R; Wallner S; Cadenas C; Gianmoena K; Floess S; Chen W; Nordstroem K; Tierling S; Olek S; Walter J; Hamann A; Syrbe U
J Immunol; 2016 Oct; 197(8):3406-3414. PubMed ID: 27591321
[TBL] [Abstract][Full Text] [Related]
34. The association between
Li J; Zhou X; Li L; Ji L; Li J; Qu Y; Wang Z; Zhao Y; Zhang J; Liang F; Liu J; Gu W; Yang R; Ma F; Dai L
Front Oncol; 2023; 13():1148635. PubMed ID: 37274256
[TBL] [Abstract][Full Text] [Related]
35. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
Yang Y; Wang M; Liu B
J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide DNA methylation profiling reveals novel epigenetic signatures in squamous cell lung cancer.
Shi YX; Wang Y; Li X; Zhang W; Zhou HH; Yin JY; Liu ZQ
BMC Genomics; 2017 Nov; 18(1):901. PubMed ID: 29169318
[TBL] [Abstract][Full Text] [Related]
37.
Liu J; Qu Y; Zhao Y; Liang F; Ji L; Wang Z; Li J; Zang Z; Huang H; Zhang J; Gu W; Dai L; Yang R
Biomarkers; 2024 Jun; ():1-11. PubMed ID: 38776382
[TBL] [Abstract][Full Text] [Related]
38. DNA methylation of KIFC1 gene in determination of histological diagnosis, prognosis and metastasis of lung cancer.
Celik B; Pasin O; Sen S; Tuncer SB; Kayım ZY; Erciyas SK; Erdogan OS; Gultaslar BK; Ghafour AA; Yazıcı H; Olgac NV
Pathol Res Pract; 2023 Sep; 249():154742. PubMed ID: 37666088
[TBL] [Abstract][Full Text] [Related]
39. DNA methylation patterns in lung carcinomas.
Pfeifer GP; Rauch TA
Semin Cancer Biol; 2009 Jun; 19(3):181-7. PubMed ID: 19429482
[TBL] [Abstract][Full Text] [Related]
40. Seven-CpG-based prognostic signature coupled with gene expression predicts survival of oral squamous cell carcinoma.
Shen S; Wang G; Shi Q; Zhang R; Zhao Y; Wei Y; Chen F; Christiani DC
Clin Epigenetics; 2017; 9():88. PubMed ID: 28852427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
